<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药信息新药开发 | wechat-feeds</title><link>http://MjM5MDk5MjU4NQ.favicon.privacyhide.com/favicon.ico</link><description>注册、BD、新药立项、研发、市场动态和竞争分析等。</description><managingEditor> (hellodword)</managingEditor><pubDate>Fri, 12 Mar 2021 16:34:14 +0800</pubDate><image><url>http://MjM5MDk5MjU4NQ.favicon.privacyhide.com/favicon.ico</url><title>医药信息新药开发 | wechat-feeds</title><link>http://MjM5MDk5MjU4NQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>报名即将截止|50+小分子药企领袖深度探讨新药研发案例、发展方向及MAH制度：PIM2021邀您3月30-31日聚首杭州！</title><link>https://mp.weixin.qq.com/s/C_-zzxscM0SqfuUYhM6znA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FAWk7vBjg6ESLRHHE9y77fYY8Vkj2Uv11mibs7gcibEvTerydaLMdDDibCvx7fqBq98L5A6PQSXKoWntzDVriaTq1g/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>3月30-31日；杭州；逐梦起航！]]></content:encoded><pubDate>Fri, 12 Mar 2021 13:48:15 +0800</pubDate></item><item><title>多动症新药：FDA批准KEMPHARM公司的Azstarys™</title><link>https://mp.weixin.qq.com/s/Ll5_9psxHmpPROGPBVlzoQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FAWk7vBjg6HHzjOFgfwAY5ican1gTkyEwqKy8xDh4btqSWmZU2RtKzRWJJLM3m79iclqQQzbyKcgt43I7jtwcUnQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>多动症新药！]]></content:encoded><pubDate>Thu, 04 Mar 2021 08:35:28 +0800</pubDate></item><item><title>药品橙皮书专利挑战概述（上）——时间节点</title><link>https://mp.weixin.qq.com/s/J-r6oRCvLQA0Kt27WCWVtg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FAWk7vBjg6G8NvUgOWaJTU6zlbfGS8iavrvkbMSficGhffBS2ib85LLFwvgvfHJGm14uQiaQhEHXD3TqwHbMm2T3rw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>药品研发属于Bolar例外，为什么还要挑战专利？]]></content:encoded><pubDate>Thu, 04 Mar 2021 07:54:26 +0800</pubDate></item><item><title>第四届新药仿药研发交流论坛-更新-2</title><link>https://mp.weixin.qq.com/s/KElzW9w0r7jOXG0cbXliTQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FAWk7vBjg6GDuwgMrp80icWDYcEdB7pT6Ncra8Vwns3FX6rChOMYZzxcbb0ENicTGXTKaJfmfKahtCX7OpzELygQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>第四届论坛-更新-2]]></content:encoded><pubDate>Tue, 02 Mar 2021 21:33:37 +0800</pubDate></item><item><title>橙皮书系列之市场独占权（4）——首仿药的180天市场独占期</title><link>https://mp.weixin.qq.com/s/KUTGx5pSbJ4cBcQuPon-Vw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FAWk7vBjg6G3HL3RszYYKpjaB9zHHtszulQWrMYvus7HqygcVrXKqcvic0bgzZa0mvR9jRk7JkSRRWHORQnxJBw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>独占权的最后一篇]]></content:encoded><pubDate>Mon, 01 Mar 2021 08:02:40 +0800</pubDate></item></channel></rss>